Medicine for the treatment of seizures listed on the PBS

The Liberal National Government will make a medicine for the treatment of seizures associated with tuberous sclerosis more affordable, saving patients $17,000 a year.   The medicine Afinitor® (everolimus) is being listed on the expert Pharmaceutical Benefits Scheme (PBS) from January 1, for the treatment of refractory seizures associated with tuberous sclerosis complex.   The…